GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Capex-to-Operating-Income

PharmaTher Holdings (XCNQ:PHRM) Capex-to-Operating-Income : 0.00 (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

PharmaTher Holdings's Capital Expenditure for the three months ended in Feb. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Feb. 2024 was C$-0.42 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


PharmaTher Holdings Capex-to-Operating-Income Historical Data

The historical data trend for PharmaTher Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Capex-to-Operating-Income Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Capex-to-Operating-Income
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's Capex-to-Operating-Income

For the Biotechnology subindustry, PharmaTher Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Capex-to-Operating-Income falls into.



PharmaTher Holdings Capex-to-Operating-Income Calculation

PharmaTher Holdings's Capex-to-Operating-Income for the fiscal year that ended in May. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -4.015
=N/A

PharmaTher Holdings's Capex-to-Operating-Income for the quarter that ended in Feb. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.422
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings  (XCNQ:PHRM) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


PharmaTher Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines